|
|
Clinical Services
Overview |
 |
Once early development studies are completed, the information learned from this process allows a pharmaceutical company to make the next critical decision: Should the company proceed with the clinical development of a therapeutic compound?
Through our state-of-the-art clinical research units in the United States and United Kingdom, Covance has helped numerous clients successfully manage the transition from nonclinical to Phase I and IIa clinical studies, enabling them to make effective and fast decisions about the safety and efficacy of their compounds.
The next step — initiation of Phase IIb and Phase III clinical trials — is a complex undertaking and represents an enormous commitment of resources. To manage projects of this magnitude, Covance draws on its broad knowledge and experience, from clinical trial service design and execution to the preparation and submission of data to regulatory authorities in multiple countries.
With clinical trial service experts located in 18 offices worldwide, Covance has one of the most experienced teams devoted exclusively to Phase II and III clinical trials. This includes numerous specialized services that support clinical development, such as:
- The largest central laboratory in the world dedicated exclusively to drug development
- Interactive Voice Response Services (IVRS)
- Cardiac Safety Services
- Centralized cardiac safety services
- Bioanalytical chemistry.
|
|
 |
|
|
|
|
|
|
